Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. May 14, 2022; 28(18): 1996-2007
Published online May 14, 2022. doi: 10.3748/wjg.v28.i18.1996
Table 5 Cox proportional hazard analysis for disease free survival
VariableP value
HR (95%CI)       
P value
HR (95%CI)       
P value
HR (95%CI)

Univariable analysis
Multivariable analysis
Multivariable analysis (excluding timing of diagnosis variable)
Age0.2751.02 (0.98-1.06)----
Gender0.7320.85 (0.34-2.13)----
Race0.9971.13 (0.15-8.51)----
BMI0.7820.99 (0.91-1.07)----
ASA score0.8170.91 (0.42-1.98)----
CCI score0.8420.98 (0.76-1.26)----
T stage 0.0212.06 (1.12-3.82)0.5041.26 (0.64-2.47)0.211.53 (0.79-2.97)
N stage0.0014.08 (1.83-9.08)0.0063.18 (1.39-7.26)0.0083.08 (1.35-7.06)
R status< 0.00111.05 (3.31-36.94)0.0065.76 (1.67-19.88)0.0026.95 (1.98-24.34)
Post-operative complications0.4040.63 (0.22-1.85)----
Non-incidental diagnosis0.0112.78 (1.26-6.12)0.092.13 (0.89-5.09)Not included in analysisNot included in analysis
Degree of differentiation0.2110.65 (0.33-1.28)----
Adjuvant chemotherapy0.4571.42 (0.56-3.58)----